Class 4 drug alert issued for PI Crestor 5mg due to ‘rogue’ blister strip
May 3 2016
An incorrect blister strip has been found in a pack of parallel imported Crestor 5mg tablets prompting a Class 4 (caution in use) drug alert.
The medicines regulator, the MHRA, said that one pack of PI Crestor 5mg tablets, batch number S347A/3153 (originator name Provisacor), “has been found to contain a rogue blister of 20mg tablets (batch S348A). The rogue blister was over labelled as 5mg tablets, batch S347A/3153. The second blister in the pack was correct (5mg).”
It has advised that, as a consequence, pharmacy stocks may still hold:
- a further 5mg carton containing a rogue blister of 20mg tablets; or
- one 20mg carton, over-labelled as 5mg S347A/3153, containing two blisters of 5mg tablets.
“Pharmacists are asked to check any remaining stock of Crestor 5mg tablets batch S347A/3153 to ensure that the carton and both blisters are correct,” said the MHRA.